# Ugandan Bugisu Coffee (Coffea arabica 'Ugandan Bugisu')

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/ugandan-bugisu-coffee
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 2 / 10
**Category:** Coffee Cultivars
**Also Known As:** Coffea arabica 'Ugandan Bugisu', Bugisu Arabica, Mount Elgon Coffee, Ugandan Bugisu Arabica, Bugisu Coffee, East Uganda Arabica, Mount Elgon Bugisu

## Overview

Ugandan Bugisu Coffee (Coffea arabica 'Ugandan Bugisu') is a specialty Arabica cultivar grown on the slopes of Mount Elgon, Uganda, notable for its exceptionally high chlorogenic acid content (30.81–55.75 mg/g) that drives potent [antioxidant activity](/ingredients/condition/antioxidant). Its primary bioactive compounds—chlorogenic acids and caffeine—interact with adenosine receptors and inhibit lipid peroxidation, supporting cellular defense mechanisms.

## Health Benefits

• [Antioxidant activity](/ingredients/condition/antioxidant): Contains chlorogenic acid (30.81-55.75 mg/g) with DPPH scavenging activity (IC50 2.22-2.59 mg/mL) - evidence from in-vitro studies only
• Natural caffeine source: Provides 0.87-1.78 mg/g caffeine in green beans - compositional data only
• Polyphenol content: Contains epicatechin, catechin, caffeic acid, and ferulic acid - no clinical evidence available
• Post-roasting melanoidins: Up to 85.51 mg/g melanoidins form during roasting - compositional data only
• No clinical trials exist for health benefits of this specific cultivar

## Mechanism of Action

Chlorogenic acids in Ugandan Bugisu Coffee, particularly 5-caffeoylquinic acid, inhibit the enzyme glucose-6-phosphatase and reduce intestinal glucose absorption by downregulating SGLT1 transporter activity, contributing to glycemic modulation. These polyphenols also scavenge [reactive oxygen species](/ingredients/condition/antioxidant) (ROS) directly, as evidenced by DPPH radical scavenging with an IC50 of 2.22–2.59 mg/mL, while upregulating endogenous antioxidant enzymes such as superoxide dismutase and catalase via Nrf2 pathway activation. Caffeine (0.87–1.78 mg/g in green beans) competitively antagonizes adenosine A1 and A2A receptors, increasing cAMP signaling, promoting alertness, and stimulating lipolysis via hormone-sensitive lipase.

## Clinical Summary

Current evidence for Ugandan Bugisu Coffee specifically is limited to in-vitro compositional and [antioxidant](/ingredients/condition/antioxidant) studies; no randomized controlled trials have been conducted using this cultivar as an isolated intervention. Broader Coffea arabica research includes human trials showing that 200–400 mg chlorogenic acid daily reduces fasting blood glucose and improves [insulin sensitivity](/ingredients/condition/weight-management) in adults with prediabetes, though these findings cannot be directly extrapolated to Bugisu without cultivar-specific trials. Caffeine content in this cultivar (up to 1.78 mg/g in green beans) falls within ranges studied in human trials demonstrating improved [cognitive performance](/ingredients/condition/cognitive) and endurance at doses of 3–6 mg/kg body weight. Overall, evidence strength for this specific cultivar remains preliminary, with mechanistic plausibility supported by its phytochemical profile rather than direct clinical data.

## Nutritional Profile

Ugandan Bugisu Coffee (green bean basis, per 100g unless noted): Macronutrients - Carbohydrates ~60g (predominantly sucrose 6-9g in green beans, degrading significantly upon roasting); Protein ~13g (including free amino acids that participate in Maillard reactions during roasting); Crude fat ~16g (primarily linoleic acid, palmitic acid, and stearic acid in coffee oil fraction); Moisture ~10-12g in green beans. Bioactive compounds (quantified): Chlorogenic acids (CGAs) 3.08-5.58g/100g green bean weight (reported as 30.81-55.75 mg/g), primarily 5-caffeoylquinic acid (5-CQA) as dominant isomer; Caffeine 87-178mg/100g green bean (0.87-1.78 mg/g), placing it within mid-range Arabica caffeine content; Trigonelline ~1.0-1.2g/100g (precursor to niacin/vitamin B3 upon roasting); Polyphenol fraction includes epicatechin, catechin, caffeic acid, and ferulic acid at trace-to-minor concentrations (individual values not yet precisely quantified for this cultivar specifically). Minerals: Potassium ~1,600-1,700mg/100g (primary mineral); Magnesium ~150-200mg/100g; Calcium ~100-130mg/100g; Phosphorus ~160-200mg/100g; trace Iron, Zinc, and Manganese present. Vitamins: Niacin (B3) precursor trigonelline converts to ~15-30mg niacin equivalent per 100g upon roasting; Riboflavin (B2) trace levels ~0.2mg/100g. Post-roasting changes: CGAs degrade by 50-70% during medium-dark roasting, generating quinides and melanoidins (high-molecular-weight Maillard products with [antioxidant](/ingredients/condition/antioxidant) and [prebiotic](/ingredients/condition/gut-health) potential); sucrose fully degraded; caffeine relatively heat-stable. Bioavailability notes: CGAs have ~33% oral bioavailability in humans, with colonic microbiota metabolizing remainder to phenolic acids (dihydrocaffeic acid, dihydroferulic acid); caffeine near-complete absorption (~99%); brewed coffee retains ~60-80% of green bean CGA content depending on roast degree and brew method. Per standard 200mL brewed cup: approximately 80-150mg caffeine, 70-200mg CGAs, and 15-30mg trigonelline-derived niacin equivalents estimated for this cultivar.

## Dosage & Preparation

No clinically studied dosage ranges are available for Ugandan Bugisu Coffee as no human trials have been conducted. General Coffea arabica compositions report chlorogenic acid at 30-55 mg/g and caffeine at 0.87-1.78 mg/g in green beans, but no standardized dosing protocols exist. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Caffeine in Ugandan Bugisu Coffee can cause [insomnia](/ingredients/condition/sleep), anxiety, tachycardia, and elevated [blood pressure](/ingredients/condition/heart-health) at high intakes (>400 mg caffeine/day for healthy adults per FDA guidance), and individuals with caffeine sensitivity, arrhythmias, or hypertension should limit consumption. Chlorogenic acids may mildly reduce iron absorption by chelating non-heme iron, which is a consideration for individuals with iron-deficiency anemia. Caffeine interacts with adenosine-based medications, monoamine oxidase inhibitors (MAOIs), anticoagulants such as warfarin (altering [metabolism](/ingredients/condition/weight-management) via CYP1A2), and certain stimulants including ephedrine, potentially amplifying cardiovascular effects. Pregnant and breastfeeding individuals should restrict caffeine intake to under 200 mg/day per ACOG guidelines, and this cultivar's variable caffeine concentration warrants careful monitoring of total daily intake.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses specific to Ugandan Bugisu Coffee were identified in the available research. Existing studies focus solely on chemical composition and in-vitro [antioxidant activity](/ingredients/condition/antioxidant) (DPPH assays) rather than biomedical outcomes, with no PubMed-indexed clinical trials found for this cultivar.

## Historical & Cultural Context

No evidence of historical or traditional medicinal use for Ugandan Bugisu Coffee appears in available research. The cultivar is primarily valued for its culinary and sensory qualities in modern coffee production, with processing methods optimized for cup quality rather than therapeutic applications.

## Synergistic Combinations

Green tea extract, L-theanine, rhodiola rosea, ashwagandha, vitamin C

## Frequently Asked Questions

### How much chlorogenic acid does Ugandan Bugisu Coffee contain?

Ugandan Bugisu Coffee contains 30.81–55.75 mg/g of chlorogenic acids in green bean form, which is among the higher ranges reported for Coffea arabica cultivars. This variability depends on altitude, processing method, and roast level, as roasting progressively degrades chlorogenic acid content—light roasts preserve significantly more than dark roasts.

### What is the caffeine content of Ugandan Bugisu green coffee beans?

Green beans of the Ugandan Bugisu cultivar contain approximately 0.87–1.78 mg/g of caffeine, placing it within the typical Arabica range of 0.9–1.7 mg/g but with notable cultivar-specific variation. A standard 8 oz brewed cup may deliver 80–120 mg of caffeine depending on roast degree, grind size, and brewing method.

### Is Ugandan Bugisu Coffee effective for antioxidant support?

In-vitro studies demonstrate that Ugandan Bugisu Coffee extracts exhibit DPPH radical scavenging activity with an IC50 of 2.22–2.59 mg/mL, indicating meaningful free-radical neutralization capacity attributable primarily to its chlorogenic acid and epicatechin content. However, these results come from cell-free laboratory assays, and no human clinical trials have confirmed that consuming this specific cultivar translates to measurable in-vivo antioxidant outcomes.

### How does Ugandan Bugisu Coffee differ from regular Arabica coffee?

Ugandan Bugisu is a specific Coffea arabica cultivar grown at elevations of 1,500–2,200 meters on the volcanic soils of Mount Elgon in eastern Uganda, conditions that promote higher polyphenol accumulation compared to lower-altitude Arabica varieties. Its chlorogenic acid concentrations (up to 55.75 mg/g) can exceed those of many commercially traded Arabica beans, making it of particular interest for both specialty flavor profiles and potential health-relevant phytochemical content.

### Can Ugandan Bugisu Coffee help with blood sugar management?

The high chlorogenic acid content of Ugandan Bugisu Coffee has mechanistic relevance to glycemic regulation, as chlorogenic acids inhibit glucose-6-phosphatase and reduce SGLT1-mediated intestinal glucose uptake—pathways studied in human trials using standardized green coffee extracts at 200–400 mg chlorogenic acid daily. No cultivar-specific clinical trials exist for Ugandan Bugisu, so blood sugar benefits remain inferred from its phytochemical profile and general Coffea arabica research rather than direct evidence.

### What is the difference between Ugandan Bugisu green coffee extract and roasted Bugisu coffee beans?

Ugandan Bugisu green coffee extract is made from unroasted beans and retains higher levels of chlorogenic acid (30.81-55.75 mg/g), while roasting significantly degrades this compound through heat exposure. Green coffee extract is typically standardized for chlorogenic acid content and used in supplements, whereas roasted coffee beans offer a lower but more bioavailable caffeine form along with developed flavor compounds. The roasting process also creates new polyphenolic compounds (melanoidins) not present in green beans, which may have different antioxidant properties.

### Does the altitude and volcanic soil of Bugisu region affect the nutrient composition of this coffee?

Ugandan Bugisu coffee is grown in the high-altitude volcanic slopes of Mount Elgon (1,400-2,000 meters), which influences the development of polyphenols and chlorogenic acid levels in the beans. The mineral-rich volcanic soil and cooler mountain climate contribute to slower bean maturation, allowing for greater accumulation of secondary metabolites like epicatechin, catechin, caffeic acid, and ferulic acid. These terroir factors are why Bugisu coffee varieties typically show higher antioxidant activity compared to lower-altitude coffee cultivars, though individual harvest and processing methods also significantly impact final composition.

### How does chlorogenic acid stability in Ugandan Bugisu Coffee change during storage and processing?

Chlorogenic acid in Ugandan Bugisu green coffee beans is relatively stable when stored in cool, dry conditions, but degrades rapidly once beans are roasted due to heat exposure and enzymatic activity. Moisture, light, and oxygen exposure during storage can also reduce chlorogenic acid content by 5-15% over several months, making proper storage in sealed, oxygen-free containers important for supplement manufacturers. For maximum chlorogenic acid retention, green coffee extract supplements typically undergo rapid processing and standardization immediately after harvesting, while roasted Bugisu coffee will have significantly lower bioavailable chlorogenic acid regardless of storage conditions.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*